Fast and efficient generation of knock-in human organoids using homology-independent CRISPR–Cas9 precision genome editing-Reference-Cited by-同舟云学术

Fast and efficient generation of knock-in human organoids using homology-independent CRISPR–Cas9 precision genome editing

Published:2020-03 Issue:3 Volume:22 Page:321-331
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Artegiani Benedetta,Hendriks Delilah,Beumer Joep,Kok Rutger^ORCID,Zheng Xuan,Joore Indi,Chuva de Sousa Lopes Susana^ORCID,van Zon Jeroen,Tans Sander,Clevers Hans^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/s41556-020-0472-5.pdf

Reference56 articles.

1. Clevers, H. Modeling development and disease with organoids. Cell 165, 1586–1597 (2016).

2. Rossi, G., Manfrin, A. & Lutolf, M. P. Progress and potential in organoid research. Nat. Rev. Genet. 19, 671–687 (2018).

3. Artegiani, B. & Clevers, H. Use and application of 3D-organoid technology. Hum. Mol. Genet. 27, R99–R107 (2018).

4. Farin, H. F. et al. Visualization of a short-range Wnt gradient in the intestinal stem-cell niche. Nature 530, 340–343 (2016).

5. Tetteh, P. W. et al. Replacement of lost Lgr5-positive stem cells through plasticity of their enterocyte-lineage daughters. Cell Stem Cell 18, 203–213 (2016).

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative genetic scissor strategies and their applications in cancer treatment and prevention: CRISPR modules and challenges;International Journal of Biological Macromolecules;2024-11

2. Liver and bile duct organoids and tumoroids;Biomedicine & Pharmacotherapy;2024-09

3. Application and prospect of organoid technology in breast cancer;Frontiers in Immunology;2024-08-26

4. Interpretation of the past, present, and future of organoid technology: an updated bibliometric analysis from 2009 to 2024;Frontiers in Cell and Developmental Biology;2024-08-13

5. Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases;Cell Stem Cell;2024-08